Navigation Links
Neurogenetic studies show proprietary compound reduces brain plaques linked to Alzheimer's
Date:9/9/2010

SAN DIEGO -- In the Sept 9, 2010 issue of Neuron, Neurogenetic Pharmaceuticals, Inc. (NGP) reports proof of concept studies that show its proprietary compound, NGP 555, is effective in preventing the amyloid pathology of Alzheimer's disease (AD) in a transgenic mouse model. The study further demonstrates that following chronic treatment with the gamma secretase modulator (GSM) compound from NGP, the mice were devoid of gastrointestinal side effects, an adverse finding commonly associated with gamma secretase inhibitors (GSIs).

A major pathological hallmark of Alzheimer's disease is an abundance of neuritic plaques in key areas of the brain involved in memory and cognition. Decades of studies have confirmed that Aβ42 forms the "seed" of these amyloid plaques, which gradually accumulate in the brain and induce neuronal cell death in the underlying brain tissue. This "toxic" molecule is generated by a stepwise process involving a pivotal enzyme, gamma secretase. Modification of gamma secretase activity to decrease production of Aβ42, thereby reducing the deposits of Aβ42 -seeded plaques, would be beneficial for the prevention of Alzheimer's disease-related pathology.

"We are pleased to make public these data on our gamma secretase modulator, NGP 555," said Dr. William T. Comer, President and CEO of Neurogenetic Pharmaceuticals. "Deposition of amyloid plaques can precede dementia by many years, and the progression of plaques to dementia reflects neuronal loss which is irreversible. We believe that halting this gradual progression of AD from pathology to dementia represents a major unmet need, especially given the growth of an aging population and the enormous cost to society for care and hospitalization. Recent advances in the use of A biomarkers in the cerebrospinal fluid and brain scans should permit early diagnosis of AD pathology and allow us to show that NGP 555 prevents the amyloid pathology."

T
'/>"/>

Contact: Tom Gable
tom@gablepr.com
877-251-3888
Gable PR
Source:Eurekalert

Page: 1 2

Related biology technology :

1. Health Robotics Releases Results of First 20 i.v.STATIONs Return On Investment (ROI) Studies in the USA and Canada
2. New hydrolysis model promising tool in cellulosic biofuel studies
3. Stretching single molecules allows precision studies of interacting electrons
4. Genomic Health Presents Six New Studies Including Four Oral Presentations in Breast, Colon and Renal Cancers at American Society of Clinical Oncology (ASCO) Annual Meeting
5. Agendia Presents Broad Array of Predictive and Prognostic Studies on Breast and Colorectal Cancers at ASCO 2010 Annual Meeting
6. Advanced Phase I and Phase II Studies of Targeted Gene Delivery Confirm That Rexin-G Impacts Survival in Chemotherapy-resistant Bone and Soft Tissue Sarcoma (ASCO 2010)
7. Studies Demonstrate Early Stage Detection and Economic Benefits of a Blood-Based Test for Lung Cancer
8. Tumor-Targeted Rexin-G Prolongs Survival in Gemcitabine-Resistant Metastatic Pancreas Cancer in Advanced Phase I and II Studies (ASCO 2010)
9. Lilly Oncology to Unveil More Than 50 Studies at ASCO 2010
10. Encorium Group, Inc. Announces New Business Contract Wins of $6.8 Million, Including Two Pivotal Phase III Studies for a Major Asian Technology Company
11. Epeius Biotechnologies Reports Major Clinical Advances: Noteworthy Clinical Case Studies in Cancer Gene Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 15, 2014 Freeslate, Inc ., ... announced that Lupin Limited, one of India’s top five ... Protégé PharmD System for high throughput solid form ... focused on a wide range of quality, affordable generic ...
(Date:1/14/2014)... 2014 Carahsoft and CDS Federal Services ... 2014 at 2pm EST (11am PST), “Natural Language Processing: ... on how technology can turn raw, heterogeneous data into ... agencies. The online webinar will last approximately one hour. ...
(Date:1/14/2014)... 14, 2014 EquitiesIQ, a leading informational ... ALQA). Alliqua is an emerging biomedical company acquiring, developing, ... care market. , Free report download: http://equitiesiq.com/reports/alliqua/ ... seasoned management team and Board, which launched the company’s ...
(Date:1/14/2014)... In recent years, growing suspicion about the ... development and promotion has led to unprecedented levels of ... concerns about the insidious impact of commercialization of research, ... to the world’s biggest pharmas for illegal marketing activities, ...
Breaking Biology Technology:Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Webcast - Natural Language Processing: Converting Raw Data into Actionable Knowledge – Hosted by Carahsoft and CDS Federal Services 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3
... Published by Medical Marketing & Media, CARY, ... in behavioral science-based relationship marketing, is ranked one ... Marketing & Media,s annual,"Agency Issue" review, published this ... for 2007, place MicroMass,among some of the largest ...
... avoid costly and potentially embarrassing mistakes when ... seems that every month there,is a news story questioning the ... controversy has been in the news. The,truth is, no matter ... used,for, mistakes are easy to make and difficult to recognize ...
... Group Purchasing Organizations Hosted,by Trane -, NATIONAL ... of,Healthcare Engineering (ASHE) offers professional learning opportunities,for its ... no exception. Added,to the roster for the first ... comfort systems and comprehensive facility solutions., Leaders ...
Cached Biology Technology:North Carolina Marketing Firm MicroMass Named One of Top 60 Healthcare Agencies in U.S. 2QualityMetric Announces QM Certified Scoring Program 2Healthcare Facility Managers Learn to Optimize Surgical Suites at 2008 ASHE Annual Conference 2Healthcare Facility Managers Learn to Optimize Surgical Suites at 2008 ASHE Annual Conference 3
(Date:4/17/2014)... have uncovered a new way the immune system may ... efforts to use immune cells to treat illness. , ... the immunological equivalent of "neighborhood police" specialized squads ... organ, instead of an entire city, the body. , ... Louis have shown that the liver, skin and uterus ...
(Date:4/17/2014)... of The Proceedings of the National ... 29, raises a number of startling questions about a ... take for granted. At the end of the last ... shifted from hunting animals and gathering fruits and tubers ... straightforward and yet the more scientists learn, the more ...
(Date:4/16/2014)... artisanal green sea turtle fishery has uncovered a stark ... what may have become an unsustainable take, according to ... of Florida. , During the research period, conservation scientists ... between 1991 and 2011, with catch rates peaking in ...
Breaking Biology News(10 mins):Some immune cells defend only 1 organ 2Genetic study tackles mystery of slow plant domestications 2Genetic study tackles mystery of slow plant domestications 3Genetic study tackles mystery of slow plant domestications 4Declining catch rates in Caribbean green turtle fishery may be result of overfishing 2Declining catch rates in Caribbean green turtle fishery may be result of overfishing 3
... Rice University have developed a lithium-ion battery that can ... rechargeable battery created in the lab of Rice materials ... the components in a traditional battery. The research appears ... Scientific Reports . "This means traditional packaging for ...
... Douglas C. Wallace, PhD, a pioneering genetics researcher who ... receive the 2012 Genetics Prize of The Gruber Foundation. ... for his groundbreaking achievements in helping science understand the ... of disease and as markers for human evolution., He ...
... tap into endogenous, highly conserved and specific catalytic ... they have the potential to enable the development ... considered un-druggable by conventional small molecule and biologics ... been hindered by the challenges encountered by identifying ...
Cached Biology News:Rice researchers develop paintable battery 2Rice researchers develop paintable battery 3$500,000 Gruber Foundation Genetics Prize goes to Philadelphia scientist 2Oligonucleotide Delivery: Biology, Engineering and Development Conference 2Oligonucleotide Delivery: Biology, Engineering and Development Conference 3
Wheat Germ Agglutinin (WGA) PS SPA Imaging Bead, 2 g. Category: Leadseeker Beads....
... Five cells (BTI-TN-5B1-4) derived from Trichoplusia ... shown to be capable of expressing ... proteins compared to other insect cells. ... features:- -Rapid doubling time as adherent cultures- Quick ...
Sf9 cells derived from Spodoptera frugiperda ovarian cells (Sf21 cells) are commonly used to isolate and propagate recombinant AcMNPV viral stocks and to produce recombinant proteins....
... Cell Medium is optimized for serum-free growth ... In this protein-free medium, Sf9 cultures routinely ... cells/ml with viabilities above 95%. This medium ... color from X-gluc staining of pBACgus recombinants ...
Biology Products: